LIPOSOME-INDUCED ACTIVATION OF THE CLASSICAL COMPLEMENT PATHWAY DOES NOT REQUIRE IMMUNOGLOBULIN

被引:60
作者
MARJAN, J
XIE, ZC
DEVINE, DV
机构
[1] UNIV BRITISH COLUMBIA, DEPT PATHOL, VANCOUVER V6T 2B5, BC, CANADA
[2] CANADIAN RED CROSS, BLOOD TRANSFUS SERV, VANCOUVER, BC, CANADA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES | 1994年 / 1192卷 / 01期
关键词
LIPOSOME; COMPLEMENT ACTIVATION;
D O I
10.1016/0005-2736(94)90140-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have investigated the contribution of immunoglobulin to the liposome-induced activation of complement in human serum. Liposomes containing the negatively charged phospholipids cardiolipin, phosphatidylglycerol or phosphatidylinositol, in addition to phosphatidylcholine and cholesterol, were used to activate complement in a whole serum system. The contribution of immunoglobulin was studied by comparing normal human serum (NHS) to serum depleted of IgG and IgM (DDS). Using hemolytic assays of complement function, greater concentrations of phospholipids were required to activate complement in the absence of immunoglobulins. Activation of the classical pathway was confirmed using a Clq ELISA which showed that activation was dependent on the presence of Clq and confirmed that greater concentrations of phospholipids were required to activate complement in the absence of immunoglobulins. Complement activation was also assessed using crossed immunoelectrophoresis of C3 activation fragments. Using immunoblot analysis, iC3b was detected on the surface of liposomes exposed to NHS or DDS. These studies demonstrate that when liposomes, containing anionic phospholipids at an equivalent charge to cardiolipin 20 mol%, are exposed to immunoglobulin depleted serum they become opsonized by complement proteins.
引用
收藏
页码:35 / 44
页数:10
相关论文
共 43 条
[1]  
AGNELLO V, 1969, FED PROC, V28, P696
[2]   LIPOSOMES WITH PROLONGED CIRCULATION TIMES - FACTORS AFFECTING UPTAKE BY RETICULOENDOTHELIAL AND OTHER TISSUES [J].
ALLEN, TM ;
HANSEN, C ;
RUTLEDGE, J .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 981 (01) :27-35
[3]  
Alving C. R., 1983, LIPOSOME LETT, P269
[4]   LIPOSOMES AS CARRIERS OF ANTIMICROBIAL AGENTS OR IMMUNOMODULATORY AGENTS IN THE TREATMENT OF INFECTIONS [J].
BAKKERWOUDENBERG, IAJM ;
LOKERSE, AF ;
TENKATE, MT ;
MELISSEN, PMB ;
VANVIANEN, W ;
VANETTEN, EWM .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 :61-67
[5]   COMPLEMENT COMPONENT-C3 FIXES SELECTIVELY TO THE MAJOR OUTER-MEMBRANE PROTEIN (MOMP) OF LEGIONELLA-PNEUMOPHILA AND MEDIATES PHAGOCYTOSIS OF LIPOSOME-MOMP COMPLEXES BY HUMAN MONOCYTES [J].
BELLINGERKAWAHARA, C ;
HORWITZ, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (04) :1201-1210
[6]   ACTIVATION OF THE ALTERNATIVE PATHWAY OF COMPLEMENT - EFFICIENT FLUID-PHASE AMPLIFICATION BY BLOCKADE OF THE REGULATORY COMPLEMENT PROTEIN BETA-1H THROUGH SULFATED POLYANIONS [J].
BITTERSUERMANN, D ;
BURGER, R ;
HADDING, U .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (04) :291-295
[7]  
CHONN A, 1991, J IMMUNOL, V146, P4234
[8]  
CHONN A, 1992, J BIOL CHEM, V267, P18759
[9]   INHIBITION OF SERUM COMPLEMENT HEMOLYTIC-ACTIVITY BY LIPID VESICLES CONTAINING PHOSPHATIDYLSERINE [J].
COMIS, A ;
EASTERBROOKSMITH, SB .
FEBS LETTERS, 1986, 197 (1-2) :321-327
[10]   LYSIS OF RNA TUMOR-VIRUSES BY HUMAN-SERUM - DIRECT ANTIBODY-INDEPENDENT TRIGGERING OF CLASSICAL COMPLEMENT PATHWAY [J].
COOPER, NR ;
JENSEN, FC ;
WELSH, RM ;
OLDSTONE, MBA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1976, 144 (04) :970-984